Fig. 2From: Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancerBaseline symptom burden. Baseline symptom burden of the 315 mTAS patients. Values range from 0 to 100, higher values represent heavier symptoms. The point ♦ in the box indicates the mean and the horizontal lines the medianBack to article page